Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

• Conditions: Graft Versus Host Disease

• Registration Number: NCT00912067
• Lead Sponsor: Sheba Medical Center

Brief Summary

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Detailed Description

Not available

Study Timeline

• Status Verified: 2009-06
• Study First Submitted: 2009-06-01
• Study First Submitted QC: 2009-06-01
• Last Update Submitted: 2009-06-01
• Study First Posted: 2009-06-03
• Last Update Posted: 2009-06-03
• Study Start: 2009-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• after hematopoietic stem cell transplantation done at sheba medical center Israel
• 3 month have past from transplantation but no more then 3 years

Exclusion Criteria

• transplantation done in the last 3 month or more than 3 years have past since

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Sheba Medical Center; 🇮🇱 Tel Hashomer, Israel